Horizon Bancorp (HBNC) CEO Disposes of 4,182 Shares; Ownership Now 46,487
Rhea-AI Filing Summary
Thomas M. Prame, CEO and reporting person of Horizon Bancorp, Inc. (HBNC), reported a sale of company common stock. On 08/15/2025 Mr. Prame disposed of 4,182 shares at $15.95 per share, reducing his direct beneficial ownership to 46,487 shares. The Form 4 was signed by an attorney-in-fact on 08/19/2025. No derivative transactions or other securities were reported on this filing. The report indicates a single non-derivative sale and shows the reporting status as an officer and CEO of the issuer.
Positive
- Full disclosure of sale amount and post-transaction ownership is provided, showing transparency of insider activity
- Form clearly identifies reporting person as CEO, aiding investor context on insider-level transactions
Negative
- No indication on the form whether the sale was made pursuant to a Rule 10b5-1 trading plan or other pre-arranged instruction
- Reason for the sale is not disclosed, so the filing does not explain the motivation behind the transaction
Insights
TL;DR Insider sale by the CEO of 4,182 shares at $15.95, leaving 46,487 shares outstanding in his direct ownership.
This Form 4 records a routine, single non-derivative disposition by the chief executive officer. The transaction is explicit: 4,182 shares sold on 08/15/2025 at $15.95, with 46,487 shares remaining beneficially owned directly. There are no derivative instruments or additional transactions reported. From a securities-monitoring perspective, the filing simply documents the sale and updated ownership; it does not provide reasons, trading plan references, or indications of patterned activity.
TL;DR A single disclosure of an insider sale by the CEO with no accompanying derivative activity or plan reference.
The filing is complete for the disclosed non-derivative sale and includes the required signature by an attorney-in-fact. It identifies the reporting person as an officer (Chief Executive Officer) and shows direct ownership after the sale. The form does not state whether the sale was pursuant to a Rule 10b5-1 plan or other arrangement, so no affirmative defense is claimed on this document.